Department of Medicine, Center for Esophageal Diseases, Baylor University Medical Center and Center for Esophageal Research, Baylor Scott & White Research Institute, Dallas, TX, USA.
Division of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, KS, USA.
Dig Dis Sci. 2021 Mar;66(3):705-713. doi: 10.1007/s10620-020-06250-1. Epub 2020 Apr 10.
Esophageal adenocarcinoma (EAC) continues to be a significant public health problem with survival rates that have remained stagnant. Although the population at the highest risk for EAC, i.e., patients with Barrett's esophagus (BE) has been clearly defined, patients with EAC continue to do poorly due to advanced stage at diagnosis. The field of extracellular vesicles (EV) could have huge application for the management of patients with BE and EAC by allowing timely diagnosis, serial monitoring, and improved understanding of disease biology. EV are actively packaged and actively secreted vesicles and contain microRNAs, proteins, lipids, and DNA. The contents of EV have been shown to provide useful insights into cellular transformation and pro-oncogenic processes. Early work shows promise but suffers from a high degree of technical and biological variation. The current review not only summarizes the current knowledge about EV as diagnostic biomarkers and their role in disease progression of BE and EAC but also provides the reader practical guidance to devise future experiments to perform well-designed studies.
食管腺癌 (EAC) 仍然是一个严重的公共卫生问题,其生存率一直停滞不前。尽管 EAC 风险最高的人群,即 Barrett 食管 (BE) 患者已经明确界定,但由于诊断时已处于晚期,EAC 患者的预后仍然很差。细胞外囊泡 (EV) 领域在 BE 和 EAC 患者的管理中具有巨大的应用潜力,可以通过及时诊断、连续监测和更好地了解疾病生物学来实现。EV 是被主动包装和主动分泌的囊泡,包含 microRNAs、蛋白质、脂质和 DNA。EV 的内容已被证明为细胞转化和致癌过程提供了有用的见解。早期的工作很有前景,但存在高度的技术和生物学变异性。本综述不仅总结了 EV 作为诊断生物标志物的现有知识及其在 BE 和 EAC 疾病进展中的作用,还为读者提供了实用的指导,以设计未来的实验,进行精心设计的研究。